As 2025 draws to a close, one word captures RealTime’s journey this year: connection.
Connection between systems that once operated in isolation. Connection between sites and sponsors who now collaborate in real time. Connection between people who believe that technology should make research easier, faster, and more human.
And the industry responded. Three of the top five CROs, nine of the top 10 site networks, and three of the world’s top-ranked hospitals now rely on RealTime, a testament to the trust, momentum, and measurable value RealTime delivered this year. From breakthrough product launches to global partnerships and industry recognition, 2025 marked the year that RealTime redefined what’s possible in clinical trial technology.
Major Product Launches
EDC Connect: The End of Duplicate Data Entry
Few things slow down clinical research more than duplicate data entry. In 2025, RealTime solved one of the industry’s oldest problems with the launch of EDC Connect, a long-awaited interoperability feature that eliminates manual data transcription between eSource and Electronic Data Capture (EDC) systems. With EDC Connect, sites can seamlessly map and export data from eSource into any ODM-compatible sponsor EDC platform, significantly saving time and reducing errors.
The launch represents a milestone for the entire industry.
For years, coordinators have spent countless hours re-entering data from one system to another, introducing errors and draining productivity. EDC Connect changes that story completely. By enabling seamless, secure, and real-time data transmission between eSource and EDC, sites and sponsors can finally experience true end-to-end data integrity.
“Imagine booking a flight on Expedia, then having to log on to United Airlines to do the same thing. That would be intolerable, right? Yet, for decades, that’s what clinical research sites have been obliged to do. Now, by allowing the eSource definitions to be mapped to their equivalents in EDC, the data may be sent electronically, using an industry-standard format. The improvements in productivity will be staggering.”
As 2026 begins, EDC Connect stands as a catalyst for collaboration and a blueprint for how site and sponsor systems can finally work as one.
TrialAlign: Data-Driven Site Selection for the Modern Era
Early in 2025, RealTime introduced TrialAlign, an advanced site selection and feasibility platform designed to bring transparency and precision to site selection.
For decades, site selection has been driven by relationships and assumptions. TrialAlign uses real-world data such as timing metrics, indication experience and historical performance, powered by RealTime-Devana, the industry’s leading business metrics-capture and analytics platform, to help sponsors and CROs identify which sites are most likely to succeed on specific studies. Ultimately, TrialAlign helps ensure that high-performing sites get the opportunities they deserve, based on measurable outcomes.
“TrialAlign brings clarity to one of the industry’s biggest blind spots: site selection.”
Strategic Partnerships
Inato × RealTime: Expanding Site Visibility Globally
Collaboration was a key theme this year. We announced a strategic partnership with Inato, merging RealTime-Devana’s robust TrialAlign site data and Inato’s trusted patient access data, providing sponsors and contract research organizations (CROs) with unparalleled insight and enabling them to choose sites that are both high-performing and ready to enroll. This combined capability supports smarter site selection and highlights our path toward integrated, data-driven trial operations.
This collaboration unites RealTime-Devana’s robust TrialAlign site data and Inato’s trusted patient access data, bridging the gap between sponsor demand and site capabilities. This partnership enables sponsors and CROs to discover high-performing sites faster, while giving sites global visibility based on their actual results.
Together, RealTime and Inato are helping shift the conversation from “Who do we know?” to “Who performs best?”- a change that promotes diversity, transparency, and opportunity across the research ecosystem.
BYOT Takes the Spotlight
Another defining milestone of 2025 was the release of the Bring Your Own Technology (BYOT) Playbook, led by the Decentralized Trials & Research Alliance (DTRA) and co-authored by RealTime Founder and Chief Strategy Officer, Rick Greenfield alongside leaders from GSK, BMS, and Mayo Clinic.
The Playbook formalized BYOT as a strategic framework for sponsor–site collaboration, empowering research organizations to use their own validated systems like eSource, eReg/eISF, and eConsent, within sponsor-funded studies.
The message was clear: sites shouldn’t have to abandon the tools that work for them to participate in modern research. With interoperability standards like CDISC ODM and FHIR guiding secure data exchange, sponsors can maintain visibility without introducing unnecessary technology burden for sites.
BYOT is a mindset shift that aligns perfectly with RealTime’s belief in site autonomy, interoperability, and patient-centered research.
Awards & Recognition
RealTime’s innovation and growth didn’t go unnoticed. In 2025, the company was recognized with two prestigious Clinical Trials Arena Excellence Awards, powered by GlobalData:. These accolades underscore two major pillars of our progress:
- Winner, Innovation in Digital Platforms: The Innovation award celebrates the transformative impact of our integrated Site Operations Management System (“SOMS”). By unifying trial oversight, regulatory compliance, participant engagement and financial operations into one eClinical system, SOMS helps sites operate with greater efficiency, accuracy, and confidence.
- Marketing / Brand Innovation: The Marketing award recognized our recent rebrand, which unified RealTime, Complion and Devana under the single RealTime eClinical Solutions identity.
These honors reflect our ongoing commitment to breakthrough technology and compelling storytelling, from the capabilities we build for AMCs, health systems, site networks, sponsors, and CROs, to the way we articulate our role in the clinical trials ecosystem. We were also proud to be Great Place to Work certified for the third year in a row, a testament to the strong culture we’ve built and overall employee satisfaction.
Executive Vision & Organizational Growth
Welcoming Kyle Cunningham, Chief Product Officer
RealTime’s momentum in 2025 was further accelerated by the addition of Kyle Cunningham as Chief Product Officer to the company’s executive leadership team.
Kyle brings deep expertise in product strategy, user experience, and life sciences technology leadership. His appointment signaled RealTime’s commitment to scaling its product ecosystem with the customer experience at the center.
Under his leadership, RealTime’s product organization continues to drive innovation across the SOMS (Site Operations Management System) platform, advancing features, integrations, and releases that deliver measurable value and continued alignment with customer needs and market evolution. He will work closely with RealTime’s Technology organization to enhance the company’s software development lifecycle (SDLC) processes and accelerate the delivery of next-generation solutions across RealTime’s entire suite of products.
“It’s an exciting time to join RealTime. My focus will be on working closely with our teams and customers to stay in tune with the challenges that matter most, and ensure we’re solving them together.”
Thought Leadership & Industry Impact
In 2025, RealTime delivered some of its most influential thought-leadership moments to date, shaping conversations on efficiency, data integrity, recruitment, and the future of eSource technology.
eSource ROI Survey Summary – RealTime Reports 2025
This edition of RealTime Reports presents findings from a global survey of 255 clinical-research professionals, showing that 74% of respondent sites currently use eSource and nearly 40% use it for 100% of their active studies; 71% of sites saved 6+ minutes per visit after implementing eSource.
The Next Chapter of eSource – RealTime Keynote 2025
At this keynote, RealTime eClinical Solutions unveiled its vision for the next era of eSource technology with eSourceOne, a purpose-built solution for Phase I clinics, and EDC Connect, a breakthrough interoperability feature that eliminates duplicate data entry between eSource and EDC.
The Recruitment Playbook for Clinical Trials – RealTime Keynote 2025
In this session, Founder & Chief Strategy Officer Rick Greenfield shared actionable strategies from top-performing sites on how to fill studies faster and smarter.
Giving Back
Of course, 2025 wasn’t all about us. This year, RealTime continued to invest in the people, organizations, and communities who move clinical research forward every day.
We were honored to once again sponsor ACRP’s Rally4Researchers, supporting access, education, and advancement for the next generation of clinical research professionals. We also continued our long-standing partnership with Greater Gift, helping celebrate clinical trial professionals and participants by passing on the gift of health to children in need around the world.
We also expanded our commitment to spotlighting excellence within our industry. For Clinical Trials Day 2025, we launched the inaugural Guiding Stars of Clinical Trials, recognizing 25 outstanding research organizations whose work is advancing science, strengthening communities, and improving patient outcomes. Their stories remind us why we do what we do, and why collaboration across our industry matters.
Know an organization who should be recognized? There’s still time to nominate a site for 2026: https://realtime-eclinical.com/guiding-stars/
Looking Ahead to 2026
RealTime enters the new year with a clear mission to continue building the complete eClinical command center for AMCs, health systems, and site networks, unifying the full operational lifecycle of research into one connected ecosystem. This isn’t just an evolution of our product suite. It’s a transformation of how clinical trials are planned, executed, and optimized.
The past year laid the foundation.
EDC Connect redefined interoperability. TrialAlign brought transparency and precision to site selection. Devana’s deep metrics enriched feasibility and forecasting. SOMS continued to unify operations across CTMS, eReg/eISF, eSource, financials, and participant engagement. And our partnerships, from Inato to the world’s top sponsor and CRO innovators, strengthened our role at the center of the research ecosystem.
In 2026, that foundation becomes a fully realized system. We will continue expanding:
- EDC Connect, enabling true ODM-driven, bidirectional data flow across site and sponsor systems.
- TrialAlign adoption, accelerating a new standard of unbiased, performance-verified feasibility.
- SOMS intelligence, integrating deeper analytics, insights, automation, and visibility across every workflow.
- Platform interoperability, making RealTime the connective tissue that links sites, sponsors, CROs, and partners in real time.
- Our partner ecosystem, ensuring sites have the opportunities, tools, and performance data needed to compete — and win — at scale.
The promise of 2026 is simple but transformative: clinical technology that finally works together, for a research ecosystem that finally works the way it should.
And as we continue building the industry’s most complete eClinical command center, one principle will guide every decision: empowering the people who move trials forward. Sites. Coordinators. Investigators. Sponsors. Networks. Patients.
Because when they succeed, the entire industry accelerates. And RealTime is committed to leading that future.
Read More: Bring Your Own Technology (BYOT): The Future of Site-Led Technology in Clinical Trials